Toleranzia Past Earnings Performance

Past criteria checks 0/6

Toleranzia's earnings have been declining at an average annual rate of -2.7%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 31.5% per year.

Key information

-2.7%

Earnings growth rate

51.1%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate31.5%
Return on equity-4.8%
Net Margin-20.3%
Next Earnings Update21 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Toleranzia makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:0EH Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2435-770
30 Jun 2433-570
31 Mar 2446-670
31 Dec 2351-760
30 Sep 2353-860
30 Jun 2345-960
31 Mar 2337-8-30
31 Dec 2235-860
30 Sep 2228-8110
30 Jun 2233-8190
31 Mar 2229-7360
31 Dec 2128-6340
30 Sep 2126-6420
30 Jun 2120-6340
31 Mar 2118-5250
31 Dec 2013-5180
30 Sep 2012-740
30 Jun 2012-740
31 Mar 208-840
31 Dec 197-840
30 Sep 195-640
30 Jun 195-540
31 Mar 194-540
31 Dec 184-640
30 Sep 184-640
30 Jun 183-540
31 Mar 183-640
31 Dec 173-540
30 Sep 172-630
30 Jun 173-630
31 Mar 173-530
31 Dec 164-530
30 Sep 164-630
30 Jun 163-630
31 Mar 163-520
31 Dec 152-420
31 Dec 142-120
31 Dec 133010

Quality Earnings: 0EH is currently unprofitable.

Growing Profit Margin: 0EH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0EH is unprofitable, and losses have increased over the past 5 years at a rate of 2.7% per year.

Accelerating Growth: Unable to compare 0EH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0EH is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.2%).


Return on Equity

High ROE: 0EH has a negative Return on Equity (-4.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 04:12
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Toleranzia AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution